The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Female Migrant Domestic Workers Experience Poor Health, Work Conditions
A review of published literature on female migrant domestic workers has found that many of them experience poor health and work conditions.
Marine Life Breeding Earlier As Oceans Warm
An international study has found that warming oceans are impacting the breeding patterns and habitat of marine life.
Monogamy Evolved In Primates To Protect Infants From Being Killed
The threat of infants being killed by unrelated males is the key driver of monogamy in primates, according to a new study by researchers.
Getting Outside The HIV Prevention ‘Comfort Zone’
More community-driven approaches to HIV prevention are needed to curb the epidemic, experts say.
Scientists Track Genetic Changes In Early Embryos
Scientists have tracked the complete set of genetic changes in a human and a mouse embryo at an unprecedented level of accuracy.
Myanmar: A Biodiversity Hotspot Under Threat
Scientists have examined the implications of economic development and climatic changes on conserving Myanmar's biodiversity.
Stem Cell Therapy For Eye Disease To Be Tested In Japan
A pilot clinical study to assess the use of stem cell therapy in wet-type age-related macular degeneration has been launched in Japan.
Thin People Get Diabetes Too, Study
A study has found that blaming fat as the cause of diabetes is misleading and wrongly promotes the idea that the condition is self-induced.
Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan
Pfizer and Takeda Pharmaceutical have launched their rheumatoid arthritis drug XELJANZ® (tofacitinib citrate) in Japan.